Standout Papers

B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approac... 2020 2026 2022 2024293
  1. B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches (2020)
    Nina Shah, Ajai Chari et al. Leukemia

Immediate Impact

1 from Science/Nature 53 standout
Sub-graph 1 of 22

Citing Papers

The present and future of bispecific antibodies for cancer therapy
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
2 intermediate papers

Works of Khalid Mezzi being referenced

Targeting MCL-1 in hematologic malignancies: Rationale and progress
2020
B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
2020 Standout

Author Peers

Author Last Decade Papers Cites
Khalid Mezzi 477 394 408 26 748
Sherilyn A. Tuazon 490 449 473 27 876
Abdul Hamid Bazarbachi 529 367 455 28 827
Harousseau Jl 593 339 291 42 743
Caitlin Costello 439 451 499 61 870
Y Harada 408 286 259 24 693
Masaharu Nobuyoshi 376 418 298 20 702
Kimberly H. Harrington 304 340 488 17 798
Pamela L. Clemens 545 322 459 32 782
Mattia D’Agostino 421 439 466 42 832
JF Rossi 462 292 466 22 917

All Works

Loading papers...

Rankless by CCL
2026